Tourmaline Bio Ownership | Who Owns Tourmaline Bio?
Tourmaline Bio Ownership Summary
Tourmaline Bio is owned by 93.42% institutional investors, 21.93% insiders. Avoro capital advisors is the largest institutional shareholder, holding 9.92% of TRML shares.
TRML Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Tourmaline Bio | 93.42% | 21.93% | -15.35% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Avoro capital advisors | 2.56M | 9.92% | $40.86M |
Ra capital management | 2.54M | 9.86% | $40.60M |
Qvt financial lp | 2.15M | 8.37% | $34.45M |
Blackrock funding, inc. /de | 1.63M | 6.34% | $26.13M |
Tcg crossover management | 1.48M | 5.74% | $23.63M |
Pfizer | 1.27M | 4.94% | $20.34M |
Blue owl capital lp | 997.11K | 3.87% | $15.94M |
Pictet asset management sa | 682.13K | 2.65% | $10.91M |
Balyasny asset management | 604.56K | 2.35% | $9.67M |
Vivo capital | 591.88K | 2.30% | $9.46M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Acuta capital partners | 283.68K | 6.33% | $4.54M |
Blue owl capital lp | 997.11K | 5.15% | $15.94M |
Pfizer | 1.27M | 3.53% | $20.34M |
Qvt financial lp | 2.15M | 3.07% | $34.45M |
Tcg crossover management | 1.48M | 2.70% | $23.63M |
Allostery investments lp | 9.36K | 1.91% | $149.60K |
Sectoral asset management | 116.51K | 1.23% | $1.86M |
Vivo capital | 591.88K | 0.97% | $9.46M |
Avoro capital advisors | 2.56M | 0.72% | $40.86M |
Ra capital management | 2.54M | 0.68% | $40.60M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Qvt financial lp | 2.15M | 3.07% | 681.28K |
Point72 asset management | 314.58K | 0.01% | 314.58K |
Pictet asset management sa | 682.13K | 0.01% | 262.25K |
Nan fung trinity (hk) | 227.09K | 0.43% | 227.09K |
Avoro capital advisors | 2.56M | 0.72% | 130.56K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Rtw investments, lp | - | - | -736.68K |
Adage capital partners gp | 135.64K | 0.00% | -364.36K |
Nan fung group | - | - | -227.09K |
Blackrock funding, inc. /de | 1.63M | 0.00% | -158.27K |
Acuta capital partners | 283.68K | 6.33% | -143.20K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Point72 asset management | 314.58K | 0.01% | 314.58K | $5.03M |
Nan fung trinity (hk) | 227.09K | 0.43% | 227.09K | $3.63M |
Sectoral asset management | 116.51K | 1.23% | 116.51K | $1.86M |
Silverarc capital management | 109.26K | 0.32% | 109.26K | $1.75M |
Susquehanna portfolio strategies | 51.12K | 0.02% | 51.12K | $817.39K |
Sold Out
Holder | Change |
---|---|
Amundi | -7.00 |
Coldstream capital management | -43.00 |
Signaturefd | -54.00 |
Lindbrook capital | -56.00 |
Jones financial companies lllp | -100.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 106 | -5.36% | 24,060,749 | 3.67% | 93 | 1.14% | 52 | -5.45% | 31 | - |
Mar 31, 2025 | 113 | 13.00% | 23,954,552 | 8.75% | 93 | 1.28% | 55 | -8.33% | 31 | 40.91% |
Dec 31, 2024 | 102 | 10.87% | 22,862,128 | 8.70% | 88 | 1.33% | 62 | 37.78% | 22 | -18.52% |
Sep 30, 2024 | 92 | 6.98% | 21,032,430 | -0.59% | 81 | 1.21% | 45 | -18.18% | 27 | 68.75% |
Jun 30, 2024 | 86 | -18.10% | 21,157,029 | 2.91% | 82 | 1.13% | 55 | -30.38% | 16 | 45.45% |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 21, 2024 | Kulkarni Sandeep Chidambar | CEO | Buy | $26.42K |
Aug 16, 2024 | Kulkarni Sandeep Chidambar | CEO | Buy | $72.00K |
Jan 29, 2024 | MCDADE MARK | - | Buy | $3.25M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | - |
2025 Q1 | - | - |
2024 Q3 | 2 | - |
2024 Q2 | - | - |
2024 Q1 | 1 | - |
TRML Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools